Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-29

Clinical Trial Update: An Efficacy and Safety Study to Compare Morphine 6-glucuronide (M6G) and Morphine in Patients Suffering With Post-Operative Pain for at Least 24 Hours [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing morphine-6-glucuronide (M6G) to morphine for postoperative pain conducted by Paion UK Ltd has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Morphine (morphine)
  • Morphine-6-glucuronide (morphine-6-glucuronide)

Snippet

Sponsor: Paion UK Ltd. | Conditions: Postoperative Pain | Phase 3 | Status: COMPLETED